Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

RBM20 Regulates CaV1.2 Surface Expression by Promoting Exon 9* Inclusion of CACNA1C in Neonatal Rat Cardiomyocytes.

Morinaga A, Ito J, Niimi T, Maturana AD.

Int J Mol Sci. 2019 Nov 8;20(22). pii: E5591. doi: 10.3390/ijms20225591.

2.

Robo2 contains a cryptic binding site for neural EGFL-like (NELL) protein 1/2.

Yamamoto N, Kashiwagi M, Ishihara M, Kojima T, Maturana AD, Kuroda S, Niimi T.

J Biol Chem. 2019 Mar 22;294(12):4693-4703. doi: 10.1074/jbc.RA118.005819. Epub 2019 Jan 30.

PMID:
30700556
3.

RBM20 and RBM24 cooperatively promote the expression of short enh splice variants.

Ito J, Iijima M, Yoshimoto N, Niimi T, Kuroda S, Maturana AD.

FEBS Lett. 2016 Jul;590(14):2262-74. doi: 10.1002/1873-3468.12251. Epub 2016 Jul 4.

4.

Leishmania tarentolae for the Production of Multi-subunit Complexes.

Niimi T.

Adv Exp Med Biol. 2016;896:155-65. doi: 10.1007/978-3-319-27216-0_10. Review.

PMID:
27165324
5.

Scaffold protein enigma homolog 1 overcomes the repression of myogenesis activation by inhibitor of DNA binding 2.

Nakatani M, Ito J, Koyama R, Iijima M, Yoshimoto N, Niimi T, Kuroda S, Maturana AD.

Biochem Biophys Res Commun. 2016 May 27;474(2):413-420. doi: 10.1016/j.bbrc.2016.04.119. Epub 2016 Apr 23.

PMID:
27114303
6.

Bio-nanocapsule-based scaffold improves the sensitivity and ligand-binding capacity of mammalian receptors on the sensor chip.

Iijima M, Yoshimoto N, Niimi T, Maturana AD, Kuroda S.

Biotechnol J. 2016 Jun;11(6):805-13. doi: 10.1002/biot.201500443. Epub 2016 Apr 20.

PMID:
27068101
7.

Mapping the heparin-binding site of the osteoinductive protein NELL1 by site-directed mutagenesis.

Takahashi K, Imai A, Iijima M, Yoshimoto N, Maturana AD, Kuroda S, Niimi T.

FEBS Lett. 2015 Dec 21;589(24 Pt B):4026-32. doi: 10.1016/j.febslet.2015.11.032. Epub 2015 Nov 26.

8.

Scaffold protein enigma homolog activates CREB whereas a short splice variant prevents CREB activation in cardiomyocytes.

Ito J, Iijima M, Yoshimoto N, Niimi T, Kuroda S, Maturana AD.

Cell Signal. 2015 Dec;27(12):2425-33. doi: 10.1016/j.cellsig.2015.09.007. Epub 2015 Sep 10.

PMID:
26365342
9.

Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy.

Liu Q, Jung J, Somiya M, Iijima M, Yoshimoto N, Niimi T, Maturana AD, Shin SH, Jeong SY, Choi EK, Kuroda S.

Int J Nanomedicine. 2015 Jun 25;10:4159-72. doi: 10.2147/IJN.S84295. eCollection 2015.

10.

Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein.

Somiya M, Sasaki Y, Matsuzaki T, Liu Q, Iijima M, Yoshimoto N, Niimi T, Maturana AD, Kuroda S.

J Control Release. 2015 Aug 28;212:10-8. doi: 10.1016/j.jconrel.2015.06.012. Epub 2015 Jun 12.

PMID:
26074149
11.

One-step scalable preparation method for non-cationic liposomes with high siRNA content.

Somiya M, Yamaguchi K, Liu Q, Niimi T, Maturana AD, Iijima M, Yoshimoto N, Kuroda S.

Int J Pharm. 2015 Jul 25;490(1-2):316-23. doi: 10.1016/j.ijpharm.2015.05.072. Epub 2015 May 28.

PMID:
26027493
12.

High-throughput de novo screening of receptor agonists with an automated single-cell analysis and isolation system.

Yoshimoto N, Tatematsu K, Iijima M, Niimi T, Maturana AD, Fujii I, Kondo A, Tanizawa K, Kuroda S.

Sci Rep. 2014 Feb 28;4:4242. doi: 10.1038/srep04242.

13.

Oligomerization-induced conformational change in the C-terminal region of Nel-like molecule 1 (NELL1) protein is necessary for the efficient mediation of murine MC3T3-E1 cell adhesion and spreading.

Nakamura Y, Hasebe A, Takahashi K, Iijima M, Yoshimoto N, Maturana AD, Ting K, Kuroda S, Niimi T.

J Biol Chem. 2014 Apr 4;289(14):9781-94. doi: 10.1074/jbc.M113.507020. Epub 2014 Feb 21.

14.

Nanocapsule-based probe for evaluating the orientation of antibodies immobilized on a solid phase.

Iijima M, Yoshimoto N, Niimi T, Maturana AD, Kuroda S.

Analyst. 2013 Jun 21;138(12):3470-7. doi: 10.1039/c3an00481c. Epub 2013 May 8.

PMID:
23653905
15.

Bio-nanocapsules for signal enhancement of alkaline phosphatase-linked immunosorbent assays.

Iijima M, Yamamoto M, Yoshimoto N, Niimi T, Kuroda S.

Biosci Biotechnol Biochem. 2013;77(4):843-6. Epub 2013 Apr 7.

16.

Exploring dynamics of molybdate in living animal cells by a genetically encoded FRET nanosensor.

Nakanishi Y, Iida S, Ueoka-Nakanishi H, Niimi T, Tomioka R, Maeshima M.

PLoS One. 2013;8(3):e58175. doi: 10.1371/journal.pone.0058175. Epub 2013 Mar 5.

17.

An automated system for high-throughput single cell-based breeding.

Yoshimoto N, Kida A, Jie X, Kurokawa M, Iijima M, Niimi T, Maturana AD, Nikaido I, Ueda HR, Tatematsu K, Tanizawa K, Kondo A, Fujii I, Kuroda S.

Sci Rep. 2013;3:1191. doi: 10.1038/srep01191. Epub 2013 Feb 1.

18.

Cell surface-fluorescence immunosorbent assay for real-time detection of hybridomas with efficient antibody secretion at the single-cell level.

Kida A, Iijima M, Niimi T, Maturana AD, Yoshimoto N, Kuroda S.

Anal Chem. 2013 Feb 5;85(3):1753-9. doi: 10.1021/ac303067k. Epub 2013 Jan 18.

PMID:
23297690
19.

Nano-visualization of oriented-immobilized IgGs on immunosensors by high-speed atomic force microscopy.

Iijima M, Somiya M, Yoshimoto N, Niimi T, Kuroda S.

Sci Rep. 2012;2:790. doi: 10.1038/srep00790. Epub 2012 Nov 9.

20.

Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells.

Matsuo H, Yoshimoto N, Iijima M, Niimi T, Jung J, Jeong SY, Choi EK, Sewaki T, Arakawa T, Kuroda S.

Int J Nanomedicine. 2012;7:3341-50. doi: 10.2147/IJN.S32813. Epub 2012 Jul 3.

Supplemental Content

Loading ...
Support Center